insights_auto
Why is 688068 down 4.05%?
Dive Deeperchevron_right
688068:SHA
Beijing Hotgen Biotech Co Ltd
CN¥72.73
arrow_downward
-4.05%(-3.07) 1D
Oct 16, 3:00:01 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 688068...
Open
CN¥77.88
High
CN¥79.49
Low
CN¥71.68
Mkt. cap
6.75B
Avg. vol.
2.28M
Volume
3.10M
52-wk high
CN¥214.78
52-wk low
CN¥71.68
EPS
-CN¥3.00
No. of employees
1K
Open
CN¥77.88
High
CN¥79.49
Low
CN¥71.68
Mkt. cap
6.75B
Avg. vol.
2.28M
Volume
3.10M
52-wk high
CN¥214.78
52-wk low
CN¥71.68
EPS
-CN¥3.00
No. of employees
1K
News stories
From web sources and news partners
TheStreet
·
35 minutes ago
Jeffrey Gundlach sees a hidden danger beneath the S&P 500
Yahoo Finance
·
5 hours ago
Sandisk Is Dominating the S&P 500 in 2026. Can It Repeat in 2027?
BeInCrypto
·
1 hour ago
Michael Burry Warns of a Stock Market ‘Supervolcano’
FOREX.com
·
7 hours ago
S&P 500, Nasdaq, Dow and Russell 2000 For the Week Ahead
Profile
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification.
Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
About Beijing Hotgen Biotech Co Ltd